Short Interest in Halberd Co. (OTCMKTS:HALB) Declines By 96.9%

Halberd Co. (OTCMKTS:HALB) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 700 shares, a drop of 96.9% from the December 15th total of 22,300 shares. Based on an average daily volume of 1,645,800 shares, the short-interest ratio is presently 0.0 days.

Halberd Stock Performance

Shares of HALB stock remained flat at $0.00 during trading on Wednesday. 22,604 shares of the stock traded hands, compared to its average volume of 377,089. Halberd has a 1 year low of $0.00 and a 1 year high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.